nvct: the income statement

MyFinsight

Nuvectis Pharma, Inc. (NVCT)

For the quarter ending 2025-06-30, NVCT made $261K in revenue. -$6,334K in net income. Net profit margin of -2426.82%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	3,613
General and administrative	2,982
Operating loss	-6,595
Finance income	261
Net loss	-6,334

Basic weighted average number of shares outstanding	21,366,268
Earnings per share, basic	-0.3
Earnings per share, diluted	-0.3
Weighted average number of shares outstanding, diluted	21,366,268

Unit: Thousand (K) dollars (except for numbers of shares and EPS)